
The International Association for the Study of Lung Cancer directs the bulk of its giving toward lung cancer research, clinical science and patient-focused advocacy. Its grants are concentrated on specialized lung cancer foundations and major cancer research centers and hospitals, supporting research programs, clinical studies, and capacity at leading institutions. The foundation favors established research partners and prominent clinical centers over small community organizations.
The International Association for the Study of Lung Cancer’s largest recent grant went to the Lung Cancer Research Foundation, a $425,000 award in 2025. That single grant is a useful window into how the foundation gives: it backs lung cancer research organizations, major cancer centers, and institutions working on clinical and translational questions tied to lung cancer and related thoracic malignancies. Another 2025 grant, $87,500 to the Lung Cancer Foundation of America, shows support for a lung cancer-specific nonprofit focused on the disease community. The remaining recent awards are smaller, $50,000 grants to major research institutions including Dana-Farber Cancer Institute, Fred Hutchinson Cancer Research Center, University of California, Los Angeles, and Mayo Clinic. Across those awards, the foundation appears to favor established partners with research infrastructure and disease-specific expertise. Its active programs also point to a global research orientation, including an IASLC Research Grant Program and a joint partnership with the Lung Cancer Research Foundation centered on oncogene-driven lung cancer. The overall picture is a funder built around lung cancer science, collaborative research, and patient-focused advancement rather than broad community grantmaking.
A clear throughline in the foundation’s grantmaking is support for lung cancer research organizations. In 2025, it gave $425,000 to the Lung Cancer Research Foundation and $87,500 to the Lung Cancer Foundation of America, both of which sit squarely in the disease-specific research and advocacy space. The foundation also funds major research and clinical institutions. It awarded $50,000 to Dana-Farber Cancer Institute for lung cancer work and another $50,000 to Fred Hutchinson Cancer Research Center, signaling interest in established centers with active cancer science programs. The same pattern appears in university-based research support: the University of California, Los Angeles received $50,000. Its active grant programs reinforce that focus, with research funding opportunities aimed at biomarker testing, molecular testing, staging projects, and thoracic oncology. The stated scope also includes related thoracic malignancies, not just lung cancer alone.
$713K
$35.6M
$28.6M
$26M
About 0% of grants go to recipients in MN.
Sign up for a free Kindora account to access AI-generated insights into this funder's giving patterns, decision-makers, and fit signals.
Get Started FreeFree Kindora accounts unlock side-by-side comparisons with foundations that share this funder's focus areas and giving profile.
Get Started FreeRegístrate gratis para ver qué tan bien se adapta tu organización sin fines de lucro a este financiador, obtener un pitch generado por IA y descubrir fundaciones similares.
Concentrated giving: a small number of relatively large grants, with a majority of funds going to repeat or high-profile research/clinical institutions rather than many small awards.
Notable grantees: Lung Cancer Research Foundation, Lung Cancer Foundation of America, Fred Hutchinson Cancer Research Center, Dana-Farber Cancer Institute, Mayo Clinic
Recent grants cluster around a few sizes: one award of $425,000, one of $87,500, and four awards of $50,000. The pattern suggests a mix of a larger anchor grant and a set of smaller institutional awards. The recent list shows repeat support to established cancer organizations and research centers in the same year, which fits a structured program rather than one-off philanthropy. The foundation is a public charity and does not fund individuals. Active programs include both IASLC-administered research funding and a partnership RFP, including one initiative described as unsolicited. Giving is organized around research opportunity structures rather than open-ended community grants.
All recent grants in the data went to U.S. recipients, with six grants and 100% of the listed total in the United States. The recipient cities span Philadelphia, New Ulm, Boston, Seattle, Los Angeles, and Minneapolis. That spread points to a multi-center research footprint rather than concentration in one metro area. The foundation’s headquarters is in Denver, but none of the recent grants listed here went to Colorado recipients.
The recent grants show support for disease-specific nonprofit research groups and major cancer research institutions. Examples include the Lung Cancer Research Foundation, the Lung Cancer Foundation of America, Dana-Farber Cancer Institute, Fred Hutchinson Cancer Research Center, the University of California, Los Angeles, and Mayo Clinic.
The foundation’s active programs and recent grants point to lung cancer research, thoracic malignancies, biomarker testing, molecular testing, staging projects, and clinical and translational research. The stated taxonomy also includes other thoracic cancers, cancer prevention and early detection, and optimizing patient care and clinical best practices.
In the recent grant list, awards range from $50,000 to $425,000. The middle of the list is anchored by several $50,000 grants, alongside one $87,500 award and one much larger $425,000 grant.
The recent grants listed here all went to U.S. recipients: six grants, representing 100% of the recipient country distribution. The active grant programs are described as global, but the recent grant examples provided are all domestic.
No. The foundation is marked as not funding individuals, and its active programs are structured as research grant programs and a request-for-proposals partnership for investigator-led research.
2025
Source: IRS Form 990-PF, fiscal year 2025.
Most recent grants reported to the IRS.
| Recipient | Location | Amount | Year | Purpose |
|---|---|---|---|---|
| LUNG CANCER RESEARCH FOUNDATION | PHILADELPHIA, PA | $425,000 | 2025 | — |
| LUNG CANCER FOUNDATION OF AMERICA | NEW ULM, MN | $87,500 | 2025 | — |
| UNIVERSITY OF CALIFORNIA | LOS ANGELES, CA | $50,000 | 2025 | — |
| FRED HUTCHINSON CANCER RESEARCH CTR | SEATTLE, WA | $50,000 | 2025 | — |
| DANA-FARBER CANCER INSTITUTE | BOSTON, MA | $50,000 | 2025 | — |
| MAYO CLINIC | MINNEAPOLIS, MN | $50,000 | 2025 | — |
| LUNG CANCER FOUNDATION OF AMERICA | NEW ULM, MN | $100,000 | 2024 | — |
| THE TRUSTEES OF INDIANA UNIVERSITY | DETROIT, MI | $11,682 | 2024 | — |
LUNG CANCER RESEARCH FOUNDATION
$425,000UNIVERSITY OF CALIFORNIA
$50,000MAYO CLINIC
$50,000THE TRUSTEES OF INDIANA UNIVERSITY
$11,682